Servier has awarded a Golden Ticket in France for the second time, giving two innovative start-ups the opportunity to join the Spartners by Servier & BioLabs incubator. This initiative aims to support and accelerate the development of promising life science projects, by providing resources, mentoring and access to a network of industry experts.
The Servier Golden Ticket, an opportunity for two start-ups
On January 23, Spartners by Servier & BioLabs, the start-up incubator at our Research and Development Institute in Paris-Saclay organized the 2nd Golden Ticket awards ceremony. This prestigious award, sponsored by Servier, grants two winning start-ups a year’s accommodation at Spartners by Servier & BioLabs.
This year’s winning start-ups are:
These start-ups will shortly be joining the incubator and will benefit from an environment conducive to innovation and the development of cutting-edge therapeutic solutions. They have access to shared, fully-equipped laboratories, events and the BioLabs network, as well as to Servier’s state-of-the-art laboratories. They will also benefit from a network of mentors and industry experts, as well as the operational resources essential to accelerating the development of their therapeutic innovation.
“Spartners by Servier & BioLabs is a unique place in France for stimulating therapeutic innovation and knowledge sharing. The combination of BioLabs’ know-how and Servier’s expertise is what makes Spartners different. The entrepreneurs can accelerate their R&D in full equipped cutting-edge laboratories while benefitting from guidance from Servier researchers in complete independance. It’s our way of contributing to entrepreneurial innovation in the service of patients!”
Céline Triquel, Head of R&D Open Innovation, Spartners Strategic & Operational Leadership, Servier
Open innovation for patients
At Servier, we understand the importance of open innovation. We consider it presents three main advantages—accelerate the speed of research, offer each project an optimal environment in which to thrive, and collaborate with the best partners for each project.
Scientific innovation by supporting biotechs and start-ups
At Servier, we firmly believe that an open approach is the best way to develop innovative therapeutic solutions that meet patients’ needs. That’s why we’re stepping up our initiatives with biotech companies with the sole aim of stimulating scientific innovation.
Each year, we support start-ups to achieve therapeutic progress through several programs:
Spartners by Servier & BioLabs, the incubator for start-ups driving therapeutic innovation
Spartners by Servier & BioLabs, the start-up incubator at the Servier Research and Development Institute is unique in France. This new synergy between the momentum of young, future-facing companies and Servier’s pharmaceutical knowledge therefore creates unique conditions that will accelerate therapeutic research.
Operated by BioLabs, the leader in shared laboratories, Spartners by Servier & BioLabs is designed to accommodate around 15 start-ups, or over 100 scientists, in a 1,850 sqm building.
Spartners by Servier & BioLabs offers shared or private laboratories, fully equipped with state-of-the-art facilities, enabling selected residents to benefit from the best equipment to accelerate their development.